Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Artblood logo — company profile

Artblood

Founded 2022 Series A Total: $6.50B Biotechnology

General Information

Company Name Artblood
Founded Year 2022
Industries Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Artblood. To contact Artblood, visit artblood.kr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Artblood compare?

A PDF of Artblood and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Artblood soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Artblood

Artblood, **Biotechnology** sektöründe faaliyet gösteren bir startup şirketidir. Şirket, 2022 yılında kurulmuş ve son olarak **KRW6.50B Series A investment** alarak büyümesini sürdürmektedir. Bu yatırım, **09 April 2024** tarihinde **Korea Development Bank, Partners Investment, Korea Investment Accelerator, Heungkuk Asset Management, One & Partners** gibi önemli yatırımcılar tarafından yapılmıştır. Artblood, sektöründeki yenilikçi yaklaşımı ve büyüme potansiyeliyle dikkat çekmektedir. The company has recently attracted significant attention in the industry with its innovative approach and growth potential. Artblood's latest investment round has positioned it for further expansion and technological advancement in the biotechnology sector.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A KRW6.50B 5
Korea Development Bank Partners Investment Korea Investment Accelerator
Korea Development Bank, Partners Investment +3
09 Apr 2024

FAQ About Artblood

Artblood was founded in 2022.
Artblood operates in Biotechnology.
Artblood has completed 1 funding round, raising a total of $6.50B. The latest funding stage is Series A.

We're actively collecting intelligence on Artblood.

Source: BounceWatch company record for Artblood, https://bouncewatch.com/company/artblood, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes